These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 3878861)

  • 21. Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma.
    Bennouna J; Bompas E; Neidhardt EM; Rolland F; Philip I; Galéa C; Salot S; Saiagh S; Audrain M; Rimbert M; Lafaye-de Micheaux S; Tiollier J; Négrier S
    Cancer Immunol Immunother; 2008 Nov; 57(11):1599-609. PubMed ID: 18301889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of advanced kidney cancer using recombinant erythropoietin].
    Morere JF; Bouillet T; Piperno-Neumann S; Tourani JM; Brunet A; Hennebelle F; Bareau JL
    Prog Urol; 1997 Jun; 7(3):399-402. PubMed ID: 9273066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Second-line thalidomide/IL-2 therapy in metastatic kidney cancer--results of a pilot study].
    Schrader AJ; Heidenreich A; Hegele A; Olbert P; Varga Z; Hofmann R
    Aktuelle Urol; 2006 Nov; 37(6):429-35; quiz 423-4. PubMed ID: 17099831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously.
    Whitehead RP; Friedman KD; Clark DA; Pagani K; Rapp L
    Clin Cancer Res; 1995 Oct; 1(10):1145-52. PubMed ID: 9815906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer.
    Portielje JE; Kruit WH; Schuler M; Beck J; Lamers CH; Stoter G; Huber C; de Boer-Dennert M; Rakhit A; Bolhuis RL; Aulitzky WE
    Clin Cancer Res; 1999 Dec; 5(12):3983-9. PubMed ID: 10632329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.
    Motzer RJ; Rakhit A; Schwartz LH; Olencki T; Malone TM; Sandstrom K; Nadeau R; Parmar H; Bukowski R
    Clin Cancer Res; 1998 May; 4(5):1183-91. PubMed ID: 9607576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma.
    Amato RJ; Malya R; Rawat A
    Am J Clin Oncol; 2008 Jun; 31(3):237-43. PubMed ID: 18525301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mistletoe therapy of metastasizing renal cancer. A phase II study].
    Kjaer M
    Ugeskr Laeger; 1988 Aug; 150(32):1923-8. PubMed ID: 3413875
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II trial of N-methylformamide for advanced renal cell carcinoma.
    Sternberg CN; Yagoda A; Scher HI; Hollander P
    Cancer Treat Rep; 1986 May; 70(5):681-2. PubMed ID: 3708620
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of pyrazoloacridine in metastatic renal cell carcinoma.
    Kuebler JP; King GW; Triozzi P; Moore T; Kraut EH
    Invest New Drugs; 2001; 19(4):327-8. PubMed ID: 11561693
    [No Abstract]   [Full Text] [Related]  

  • 31. AE 941--Neovastat.
    Drugs R D; 1999 Feb; 1(2):135-6. PubMed ID: 10566006
    [No Abstract]   [Full Text] [Related]  

  • 32. NCI to sponsor phase III trials of liquid shark cartilage angiogenesis inhibitor.
    Oncology (Williston Park); 1999 Jan; 13(1):82. PubMed ID: 10223792
    [No Abstract]   [Full Text] [Related]  

  • 33. [Phase I-II studies on various types of interferon against malignant tumors].
    Mitachi Y; Kambe M; Asamura M; Wakui A
    Nihon Gan Chiryo Gakkai Shi; 1988 Jan; 23(1):33-42. PubMed ID: 2454276
    [No Abstract]   [Full Text] [Related]  

  • 34. Nephrotic syndrome after injections of bovine cartilage and marrow extract.
    Schacht E; Roetz R
    Lancet; 1989 Apr; 1(8644):963. PubMed ID: 2565457
    [No Abstract]   [Full Text] [Related]  

  • 35. Shark cartilage for cancer?
    Ernst E
    Lancet; 1998 Jan; 351(9098):298. PubMed ID: 9457132
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of human cancer with agents prepared from bovine cartilage.
    Prudden JF
    J Biol Response Mod; 1985 Dec; 4(6):551-84. PubMed ID: 4087031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor activity of bovine cartilage extract (Catrix-S) in the human tumor stem cell assay.
    Durie BG; Soehnlen B; Prudden JF
    J Biol Response Mod; 1985 Dec; 4(6):590-5. PubMed ID: 4087032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase II study of Catrix-S in solid tumors.
    Romano CF; Lipton A; Harvey HA; Simmonds MA; Romano PJ; Imboden SL
    J Biol Response Mod; 1985 Dec; 4(6):585-9. PubMed ID: 3878861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case study of metastatic renal cell carcinoma in lungs showing complete response to continuous subcutaneous injection of interferon alpha and gamma].
    Kawata N; Hirakata H; Igarashi T; Minei S; Hamano K; Kodama M; Yamamoto T; Takimoto Y
    Hinyokika Kiyo; 1996 Jul; 42(7):509-12. PubMed ID: 8809559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.
    Clark PE; Hall MC; Miller A; Ridenhour KP; Stindt D; Lovato JF; Patton SE; Brinkley W; Das S; Torti FM
    Urology; 2004 Jun; 63(6):1061-5. PubMed ID: 15183950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.